Tenet Healthcare (NYSE:THC – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Truist Financial in a note issued to investors on Tuesday, Benzinga reports. They presently have a $305.00 price target on the stock, up from their previous price target of $290.00. Truist Financial‘s target price suggests a potential upside […]

Journey Medical (NASDAQ:DERM – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $13.00 price target on the stock. HC Wainwright‘s price objective would suggest a potential upside of 162.36% from the […]